Equities researchers at StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Get Free Report) in a report released on Tuesday. The firm set a “hold” rating on the stock.
TherapeuticsMD Trading Down 0.3 %
Shares of TXMD opened at $1.58 on Tuesday. TherapeuticsMD has a twelve month low of $1.43 and a twelve month high of $3.07. The business’s 50-day moving average price is $1.70 and its 200-day moving average price is $1.83.
TherapeuticsMD (NASDAQ:TXMD – Get Free Report) last posted its earnings results on Monday, August 12th. The company reported ($0.09) earnings per share for the quarter. The company had revenue of $0.23 million for the quarter.
Institutional Investors Weigh In On TherapeuticsMD
About TherapeuticsMD
TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.
Read More
- Five stocks we like better than TherapeuticsMD
- How to Calculate Stock Profit
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- How to Buy Cheap Stocks Step by Step
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- The 3 Best Blue-Chip Stocks to Buy Now
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.